证券日报网讯 8月22日晚间，华润双鹤发布公告称，2025年半年度公司实现营业收入5，741，509， 806.80元，同比下降3.16%；归属于上市公司股东的净利润975，491，614.76元，同比下降6.79%。 （文章来源：证券日报） ...

Core Viewpoint - China Resources Double Crane announced a cash dividend plan for the first half of 2025, proposing a distribution of 1 yuan per 10 shares (including tax), totaling approximately 104 million yuan, which represents 10.65% of the company's net profit [2][3]. Financial Performance - The company reported a revenue of 5.742 billion yuan for the first half of 2025, a year-on-year decrease of 3.16% [3]. - The net profit for the same period was 975 million yuan, down 6.79% year-on-year, with basic earnings per share at 0.948 yuan and a weighted average return on equity of 8.99% [3]. Dividend History - This marks the 26th cash distribution since the company's listing, with the latest dividend representing a dividend yield of 0.53% [2][3]. - Historical dividend distributions include: - 2024.12.31: 3.71 yuan per 10 shares, total cash of 385 million yuan, yield of 1.80% - 2023.12.31: 2.57 yuan per 10 shares, total cash of 267 million yuan, yield of 1.41% [2]. Market Position - In the pharmaceutical and biotechnology sector, 26 companies announced their dividend plans for the first half of 2025, with WuXi AppTec leading with a cash distribution of 1 billion yuan [5]. - China Resources Double Crane's cash distribution ranks lower compared to peers, with a total cash payout of 103.88 million yuan, placing it among the lower tier in terms of cash distribution [5][6].

Core Viewpoint - China Resources Double Crane announced a cash dividend distribution plan for the first half of 2025, proposing a cash dividend of 1.00 yuan (including tax) for every 10 shares held by shareholders [1] Summary by Relevant Sections - **Dividend Distribution** - The company plans to distribute a total cash dividend of 103,875,750.90 yuan (including tax) based on the number of shares after the cancellation of 79,013 restricted shares [1] - This cash dividend represents 10.65% of the net profit attributable to shareholders of the listed company for the first half of 2025 [1] - **Share Capital Information** - As of June 30, 2025, the total share capital of the company is 1,038,836,522 shares, which will be adjusted to 1,038,757,509 shares after the cancellation of restricted shares [1]

Core Viewpoint - China Resources Double Crane (600062.SH) reported a decline in revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved operating revenue of 5.742 billion yuan, a year-on-year decrease of 3.16% [1] - The net profit attributable to shareholders was 975 million yuan, down 6.79% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 933 million yuan, showing a year-on-year increase of 1.21% [1] - Basic earnings per share were reported at 0.948 yuan [1]

格隆汇8月22日丨华润医药(03320.HK)发布公告，华润双鹤(600062.SH)2025年上半年实现营业收入57.42 亿元(人民币，下同)，同比下降3.2%；归属于华润双鹤股东的净利润9.75亿元，同比下降6.79%，每股 基本盈利人民币0.948元。 ...

Group 1 - The core viewpoint of the article is that China Resources Pharmaceutical (03320) reported a decline in its mid-year performance for 2025, with total revenue approximately 5.7415 billion yuan, a year-on-year decrease of 3.16% [1] - The net profit attributable to shareholders of the listed company is approximately 975 million yuan, reflecting a year-on-year decrease of 6.79% [1] - The basic earnings per share are reported at 0.9480 yuan, with a cash dividend distribution of 1 yuan per 10 shares (including tax) [1]

华润双鹤药业股份有限公司 2025 年半年度报告 华润双鹤药业股份有限公司 2025 年半年度报告 公司代码：600062 公司简称：华润双鹤 华润双鹤药业股份有限公司 华润双鹤药业股份有限公司 2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、 准确性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 未出席董事情况 未出席董事职务 未出席董事姓名 未出席董事的原因说明 被委托人姓名 董事长 陆文超 工作原因 赵骞 三、 本半年度报告未经审计。 四、 公司负责人陆文超、主管会计工作负责人黄文昊及会计机构负责人(会计主管人员)于 长久声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司2025年半年度拟以实施权益分派股权登记日登记的总股本为基数分配利润，拟向 全体股东每10股派发现金红利1.00元(含税)。 根据截至2025年6月30日公司总股本1,038,836,522股，扣除2025年7月30日回购注销 元，结转以后年度分配。 如在本次利润分配 ...

Core Points - The company plans to distribute a cash dividend of 1.00 yuan (including tax) for every 10 shares to all shareholders based on the total share capital as of the dividend distribution date [1][2] - The total share capital as of June 30, 2025, is 1,038,836,522 shares, with adjustments to be made if there are changes in share capital due to convertible bonds, share buybacks, or other significant events [1] - The profit distribution plan is subject to approval by the shareholders' meeting [2] Company Overview - The company is listed on the Shanghai Stock Exchange under the stock code 600062, with the stock name "华润双鹤" [3] - As of the end of the reporting period, the total assets amount to approximately 16.74 billion yuan, showing a slight increase of 0.33% compared to the previous year [3] - The net assets attributable to shareholders increased by 6.08% year-on-year, reaching approximately 11.04 billion yuan [3] Financial Performance - The company's operating revenue for the reporting period is approximately 5.74 billion yuan, a decrease of 3.16% compared to the same period last year [3] - The total profit for the period is approximately 1.22 billion yuan, reflecting a growth of 2.05% year-on-year [3] - The net profit attributable to shareholders decreased by 6.79% to approximately 975.49 million yuan [3] - The net cash flow from operating activities decreased by 29.24% to approximately 662.17 million yuan [3] - The basic and diluted earnings per share are both 0.9480 yuan, down by 7.05% compared to the previous year [3] Shareholder Information - The largest shareholder is Beijing Pharmaceutical Group Co., Ltd., holding 60.24% of the shares [4] - The total number of shareholders as of the reporting period is 57,431 [3]

第十届董事会第十三次会议 2025 年 8 月 21 日 证券代码：600062 证券简称：华润双鹤 公告编号：临 2025－067 华润双鹤药业股份有限公司 第十届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 一、董事会会议召开情况 公司第十届董事会第十三次会议的召开符合《公司法》和公司《章 程》的有关规定。本次会议通知和材料于 2025 年 8 月 11 日以邮件方 式向全体董事发出，会议于 2025 年 8 月 21 日以现场及通讯方式召开。 出席会议的董事应到 11 名，亲自出席会议的董事 10 名。董事长陆文 超先生因工作原因委托董事赵骞先生出席会议，并授权对本次会议通 知中所列议题代行同意的表决权。会议由半数以上董事共同推选赵骞 先生主持。公司监事列席会议。公司董事会秘书刘驹先生列席会议。 二、董事会会议审议情况 详见上海证券交易所网站 www.sse.com.cn。 《2025 年半年度报告》 《 2025 年 半 年 度 报 告 摘 要 》 详 见 上 海 证 券 交 易 所 网 ...

Core Viewpoint - The company announced a profit distribution plan for the first half of 2025, proposing a cash dividend of 0.1 RMB per share (before tax) [1][2]. Summary by Sections Profit Distribution Plan - As of June 30, 2025, the company's undistributed profits amounted to 6,004,798,406.10 RMB [1]. - The proposed distribution is 1.00 RMB (before tax) for every 10 shares held, based on the total share capital registered on the dividend distribution date [1][2]. - The total amount of cash dividends cannot be determined until the actual number of shares entitled to participate in the distribution is known [1]. Decision-Making Process - The company's board of directors held the 13th meeting of the 10th board on August 21, 2025, where the profit distribution proposal was approved with 11 votes in favor and no opposition [2]. - The proposal aligns with the company's profit distribution policy as outlined in its articles of association [2]. - The supervisory board supports the proposal, stating it balances shareholder returns with the company's operational needs and sustainable development [2].